CRER-401E Heart Lung Machine and Related Items

SUNY Stony Brook University Hospital has initiated a sole-source procurement for a Heart Lung Machine and related items through a direct award to LivaNova USA, Inc. This procurement has been granted an exemption from standard advertising requirements by the Office of the State Comptroller, indicating a unique acquisition process. The contract will cover all New York State counties and is scheduled to commence on October 2, 2025, with a termination date of June 30, 2026. The specific medical equipment being procured includes a Heart Lung Machine and associated peripheral items, which are likely critical for surgical and medical interventional procedures. The procurement documents indicate this is a targeted, specialized acquisition with LivaNova USA, Inc. identified as the exclusive provider, suggesting unique technological capabilities or proprietary specifications that cannot be met by alternative vendors. The advertisement for this opportunity will remain active until October 1, 2025, providing a narrow window for potential inquiries or comments regarding the procurement.

The procurement appears to be a direct, single-source award with no explicit set-aside designations for disadvantaged business enterprises or specific organizational restrictions. As a sole-source procurement for a specialized medical device, the opportunity is likely limited to the identified vendor, LivaNova USA, Inc. While specific budget ranges are not disclosed in the provided documentation, medical equipment of this sophistication typically represents a significant capital investment for healthcare institutions. The procurement is specifically for SUNY Stony Brook University Hospital, indicating an institutional-level acquisition rather than a broader state-wide contract. The heart lung machine and related items suggest this is a critical medical technology procurement intended to support advanced surgical capabilities at the university hospital. No information is provided about incumbent vendors or existing technological infrastructure, though the sole-source designation implies a strategic, targeted procurement with specific technological requirements.